Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1997
Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expressionE Chuang, M L Alegre, C S Duckett, et al.
The EMBO Journal|September 1, 1993
A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activationN D Perkins, N L Edwards, C S Duckett, et al.
European Journal of Immunology|November 28, 2000
Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicityH Nakajima, M Cella, A Bouchon, et al.
The Journal of Biological Chemistry|December 7, 2000
c-IAP1 is cleaved by caspases to produce a proapoptotic C-terminal fragmentR J Clem, T T Sheu, B W Richter, et al.
The Journal of Biological Chemistry|September 22, 2001
SNIP1 inhibits NF-kappa B signaling by competing for its binding to the C/H1 domain of CBP/p300 transcriptional co-activatorsR H Kim, K C Flanders, S Birkey Reffey, et al.
Molecular and Cellular Biology|March 1, 1993
Dimerization of NF-KB2 with RelA(p65) regulates DNA binding, transcriptional activation, and inhibition by an I kappa B-alpha (MAD-3)C S Duckett, N D Perkins, T F Kowalik, et al.
Genes & Development|December 1, 1992
The proto-oncogene bcl-3 encodes an I kappa B proteinL D Kerr, C S Duckett, P Wamsley, et al.
Cell Death and Differentiation|February 9, 2008
X-linked inhibitor of apoptosis deficiency in the TRAMP mouse prostate cancer modelC Hwang, K A Oetjen, D Kosoff, et al.
Pageof 4